Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mesenchymal stromal cells protect combined oncolytic and helper-dependent adenoviruses from humoral immunity

Molecular Therapy — Methods & Clinical Development(2024)10.1016/j.omtm.2024.101279Source: DataRank Database

Mesenchymal stromal cells protect combined oncolytic and helper-dependent adenoviruses from humoral immunity is a research paper published in Molecular Therapy — Methods & Clinical Development (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.15)OA: goldTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Arianexys Aquino Lόpez,A Wolff ORCID,Audrey Ma,Amanda Rosewell Shaw ORCID,Masataka Suzuki ORCID

Live enrichment

PubMed:38993326 PMC:PMC11238183 OpenAlex:https://openalex.org/W4399391167

National Heart Lung and Blood Institute

Grant: 5T32HL092332-17

Training In Cell and Gene Therapy

National Cancer Institute

Grant: 5PO1CA094237-15

NHLBI NIH HHS

Grant: T32 HL092332

National Institutes of Health

Grant: 5P01CA094237-10

CELL PROCESSING

Tessa Therapeutics

AstraZeneca

National Institutes of Health

FWCI

1.15

Citation Percentile

0.8%

Citation Trend

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.omtm.2024.101279

publisherhttps://doi.org/10.1016/j.omtm.2024.101279

publisherhttps://api.elsevier.com/content/article/PII:S2329050124000950?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2329050124000950?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38993326

Fields of Study

Virus-based gene therapy researchCAR-T cell therapy researchRNA Interference and Gene Delivery0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Oncolytic virusMesenchymal stem cellOncolytic adenovirusHoming (biology)Stromal cellImmunologyCancer researchBiologyImmune systemVirologyMedicineCell biologySolid TumorsMesenchymal Stromal CellsHelper-dependent AdenovirusThree-dimensional Tumor SpheroidsMedical SciencesQH573-671Brief Report610QH426-470620GeriatricsInternal MedicineMedical SpecialtiesMedicine and Health SciencesGeneticsCytology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Zero hunger

Mesenchymal stromal cells protect combined oncolytic and helper-dependent adenoviruses from humoral immunity

FAIR Checklist

Authors (8)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)